Back to Atlas
BSemi-durableStandard research/education caution
CMP-0236
Regional approval/research
Semax
Nootropic / Neurotrophic
Cognition, attention and neuroprotection positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- ACTH fragment/neurotrophic signaling
- Primary market use
- Cognition
Pharmacology
- Molecular weight (Da)
- 813.9
- Oral bioavailability
- N/A/intranasal
- Half-life
- ~5–60 min parent peptide; analogs may be longer
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Human/Regional
- Clinical status
- Regional approval/research
- Value-for-money score
- 6 / 10
Reported protocol signal
Intranasal: • 750-1000 mcg daily in the morning (Dr. Seeds) SQ: • 100-300 mcg daily in the morning (Dr. Seeds)
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Found in supplier and EveryChem-style catalogs